Hydrocortisone therapy in meconium aspiration syndrome

A controlled study

T. F. Yeh, G. Srinivasan, V. Harris, R. S. Pildes

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

To evaluate the efficacy of glucocorticoids in the treatment of infants with meconium aspiration syndrome, a double-blind study using hydrocortisone or a lactose placebo was undertaken. Thirty-five infants were included in the study. No significant differences in arterial Po2, Pco2, pH, A-aDo2 gradients, in requirement for assisted ventilation, or in survival were demonstrated between the groups. In control infants, a significant decrease (p<0.01) in respiratory distress score was found at 48 to 72 hours of age; in treated infants, it was seen only after 72 hours. The infants in the treated group took a significantly longer (p<0.01) period of time to wean to room air than those in the control group (68.9±9.6 hours vs 36.6±6.9 hours). On the basis of these observations, hydrocortisone is not recommended for treatment of MAS.

Original languageEnglish
Pages (from-to)140-143
Number of pages4
JournalThe Journal of Pediatrics
Volume90
Issue number1
DOIs
Publication statusPublished - Jan 1 1977
Externally publishedYes

Fingerprint

Meconium Aspiration Syndrome
Hydrocortisone
Therapeutics
Lactose
Double-Blind Method
Glucocorticoids
Ventilation
Air
Placebos
Control Groups

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Hydrocortisone therapy in meconium aspiration syndrome : A controlled study. / Yeh, T. F.; Srinivasan, G.; Harris, V.; Pildes, R. S.

In: The Journal of Pediatrics, Vol. 90, No. 1, 01.01.1977, p. 140-143.

Research output: Contribution to journalArticle

Yeh, T. F. ; Srinivasan, G. ; Harris, V. ; Pildes, R. S. / Hydrocortisone therapy in meconium aspiration syndrome : A controlled study. In: The Journal of Pediatrics. 1977 ; Vol. 90, No. 1. pp. 140-143.
@article{d7d98fbe8d9541fe8bcdb4fe6967a15b,
title = "Hydrocortisone therapy in meconium aspiration syndrome: A controlled study",
abstract = "To evaluate the efficacy of glucocorticoids in the treatment of infants with meconium aspiration syndrome, a double-blind study using hydrocortisone or a lactose placebo was undertaken. Thirty-five infants were included in the study. No significant differences in arterial Po2, Pco2, pH, A-aDo2 gradients, in requirement for assisted ventilation, or in survival were demonstrated between the groups. In control infants, a significant decrease (p<0.01) in respiratory distress score was found at 48 to 72 hours of age; in treated infants, it was seen only after 72 hours. The infants in the treated group took a significantly longer (p<0.01) period of time to wean to room air than those in the control group (68.9±9.6 hours vs 36.6±6.9 hours). On the basis of these observations, hydrocortisone is not recommended for treatment of MAS.",
author = "Yeh, {T. F.} and G. Srinivasan and V. Harris and Pildes, {R. S.}",
year = "1977",
month = "1",
day = "1",
doi = "10.1016/S0022-3476(77)80789-0",
language = "English",
volume = "90",
pages = "140--143",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Hydrocortisone therapy in meconium aspiration syndrome

T2 - A controlled study

AU - Yeh, T. F.

AU - Srinivasan, G.

AU - Harris, V.

AU - Pildes, R. S.

PY - 1977/1/1

Y1 - 1977/1/1

N2 - To evaluate the efficacy of glucocorticoids in the treatment of infants with meconium aspiration syndrome, a double-blind study using hydrocortisone or a lactose placebo was undertaken. Thirty-five infants were included in the study. No significant differences in arterial Po2, Pco2, pH, A-aDo2 gradients, in requirement for assisted ventilation, or in survival were demonstrated between the groups. In control infants, a significant decrease (p<0.01) in respiratory distress score was found at 48 to 72 hours of age; in treated infants, it was seen only after 72 hours. The infants in the treated group took a significantly longer (p<0.01) period of time to wean to room air than those in the control group (68.9±9.6 hours vs 36.6±6.9 hours). On the basis of these observations, hydrocortisone is not recommended for treatment of MAS.

AB - To evaluate the efficacy of glucocorticoids in the treatment of infants with meconium aspiration syndrome, a double-blind study using hydrocortisone or a lactose placebo was undertaken. Thirty-five infants were included in the study. No significant differences in arterial Po2, Pco2, pH, A-aDo2 gradients, in requirement for assisted ventilation, or in survival were demonstrated between the groups. In control infants, a significant decrease (p<0.01) in respiratory distress score was found at 48 to 72 hours of age; in treated infants, it was seen only after 72 hours. The infants in the treated group took a significantly longer (p<0.01) period of time to wean to room air than those in the control group (68.9±9.6 hours vs 36.6±6.9 hours). On the basis of these observations, hydrocortisone is not recommended for treatment of MAS.

UR - http://www.scopus.com/inward/record.url?scp=0017350580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017350580&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(77)80789-0

DO - 10.1016/S0022-3476(77)80789-0

M3 - Article

VL - 90

SP - 140

EP - 143

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -